BeOne Medicines Ltd. (ONC)
NASDAQ: ONC
· Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT
BeOne Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.32B | 1.12B | 1.13B | 1B | 929.17M | 751.65M | 634.41M | 781.31M | 595.26M | 447.8M | 380.1M | 387.63M | 341.57M | 306.63M | 213.98M | 206.44M | 149.99M | 605.87M |
Cost of Revenue | 164.61M | 165M | 160.56M | 170.46M | 138.13M | 124.94M | 105.83M | 96.31M | 518.75M | 490.37M | 519.54M | 502.91M | 449.38M | 455.15M | 479.03M | 399.35M | 392.35M | 353.41M |
Gross Profit | 1.15B | 952.28M | 967.26M | 831.14M | 791.03M | 626.72M | 528.58M | 685M | 76.51M | -42.57M | -139.45M | -115.28M | -107.81M | -148.53M | -265.05M | -192.91M | -242.36M | 252.46M |
Operating Income | 87.89M | 11.1M | -79.42M | -120.27M | -107.16M | -261.35M | -383.8M | -133.97M | -318.71M | -371.26M | -468.62M | -438.36M | -439.4M | -443.29M | -571.74M | -462.32M | -474.84M | 70.17M |
Interest Income | 3.5M | 5.85M | 7.81M | 10.64M | 13.22M | 16.16M | n/a | 26.65M | 15.07M | 16.02M | 18.22M | 12.76M | 11.43M | 10.07M | n/a | n/a | n/a | n/a |
Pretax Income | 99.55M | 20.9M | -85.35M | -98.3M | -105.92M | -243.43M | -350.77M | 229.34M | -367.46M | -336.94M | -430.96M | -551.24M | -557.59M | -421.25M | -586.8M | -433.08M | -480.57M | 61.87M |
Net Income | 94.32M | 1.27M | -151.88M | -121.35M | -120.41M | -251.15M | -2.66B | 215.41M | -381.14M | -348.43M | -3.17B | -557.56M | -571.45M | -434.27M | -585.65M | -413.86M | -480.34M | 66.5M |
Selling & General & Admin | 537.91M | 459.27M | 504.68M | 455.22M | 443.73M | 427.43M | 416.55M | 364.42M | 395.03M | 328.5M | 328.98M | 322.89M | 331.4M | 294.57M | 306.5M | 269.23M | 232.29M | 182.11M |
Research & Development | 524.9M | 481.89M | 542.01M | 496.18M | 454.47M | 460.64M | 493.99M | 453.26M | 422.76M | 408.58M | 446.02M | 426.36M | 378.21M | 389.92M | 430.49M | 351.94M | 356.09M | 320.73M |
Other Expenses | n/a | 17K | n/a | n/a | n/a | 1.76M | n/a | n/a | -63.82M | 187K | 188K | 187K | 188K | 188K | -10.58M | 31.48M | -867K | -4.12M |
Operating Expenses | 1.06B | 941.17M | 1.05B | 951.4M | 898.2M | 888.07M | 912.37M | 818.97M | 395.22M | 328.69M | 329.17M | 323.08M | 331.59M | 294.76M | 306.69M | 269.42M | 232.48M | 182.29M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.22M | 12.76M | 11.43M | 10.07M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.23B | 1.11B | 1.21B | 1.12B | 1.04B | 1.01B | 1.02B | 915.28M | 913.98M | 819.06M | 848.72M | 825.99M | 780.97M | 749.91M | 785.72M | 668.76M | 624.83M | 535.71M |
Income Tax Expense | 5.23M | 19.63M | 66.53M | 23.05M | 14.48M | 7.72M | 121.3M | 13.93M | 13.67M | 11.49M | 102.26M | 6.32M | 13.86M | 13.03M | -1.15M | -19.22M | -230K | -4.63M |
Shares Outstanding (Basic) | 8.33M | 106.93M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 104.67M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 91.46M |
Shares Outstanding (Diluted) | 8.66M | 111.17M | 106.26M | 104.7M | 104.7M | 104.27M | 104.08M | 106.95M | 104.63M | 104.17M | 103.76M | 103.48M | 102.8M | 102.46M | 95.03M | 92.77M | 91.85M | 96.73M |
EPS (Basic) | 11.83 | 0.01 | -1.43 | -1.16 | -1.15 | -2.47 | -25.48 | 2.08 | -3.64 | -3.38 | -30.55 | -5.33 | -5.59 | -4.29 | -6.11 | -4.42 | -5.2 | 0.78 |
EPS (Diluted) | 10.14 | 0.01 | -1.43 | -1.16 | -1.15 | -2.47 | -25.48 | 1.95 | -3.64 | -3.38 | -30.55 | -5.33 | -5.59 | -4.29 | -6.11 | -4.42 | -5.2 | 0.65 |
EBITDA | 123.5M | 43.91M | -29.18M | -48.97M | -83.05M | -236.06M | -359.98M | -112.46M | -296.38M | -351.25M | -450.61M | -422.16M | -423.94M | -426.69M | -558.62M | -450.15M | -463.31M | 79.8M |
EBIT | 87.89M | 11.1M | -79.42M | -120.27M | -107.16M | -261.35M | -383.8M | -133.97M | -318.71M | -371.26M | -468.62M | -438.36M | -439.4M | -443.29M | -571.74M | -462.32M | -474.84M | 70.17M |
Depreciation & Amortization | 35.61M | 32.8M | 50.25M | 71.29M | 24.11M | 25.29M | 23.82M | 21.51M | 22.34M | 20.01M | 18.02M | 16.2M | 15.46M | 16.6M | 13.12M | 12.18M | 11.53M | 9.63M |